Form ARS Kiniksa Pharmaceuticals For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
- Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted EBITDA Guidance of $485 to $525 Million
- Vital Infrastructure Reports Second Quarter 2026 Results; Advances Over $150 Million of North American Acquisitions
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
